vs
OFG BANCORP（OFG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是OFG BANCORP的1.1倍（$197.9M vs $184.3M），OFG BANCORP净利率更高（30.3% vs 6.7%，领先23.6%），REPLIGEN CORP同比增速更快（13.6% vs 0.9%），OFG BANCORP自由现金流更多（$199.3M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.8%）
OFG Bancorp成立于1964年，总部位于波多黎各圣胡安，是东方银行的金融控股公司。公司通过东方银行、东方金融服务有限责任公司、东方保险有限责任公司等核心子公司，主要面向波多黎各和美属维尔京群岛市场，提供多元化的零售与商业银行、贷款、财富管理相关产品、服务及技术解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
OFG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$184.3M
营收增速更快
RGEN
高出12.8%
0.9%
净利率更高
OFG
高出23.6%
6.7%
自由现金流更多
OFG
多$181.8M
$17.6M
两年增速更快
RGEN
近两年复合增速
2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $184.3M | $197.9M |
| 净利润 | $55.9M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 25.7% | 9.0% |
| 净利率 | 30.3% | 6.7% |
| 营收同比 | 0.9% | 13.6% |
| 净利润同比 | 11.0% | 143.9% |
| 每股收益（稀释后） | $1.27 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFGRGEN
| Q4 25 | $184.3M | $197.9M | ||
| Q3 25 | $186.2M | $188.8M | ||
| Q2 25 | $182.4M | $182.4M | ||
| Q1 25 | $178.6M | $169.2M | ||
| Q4 24 | $182.7M | $174.1M | ||
| Q3 24 | $174.7M | $154.9M | ||
| Q2 24 | $179.8M | $154.1M | ||
| Q1 24 | $174.4M | $151.3M |
净利润OFGRGEN
| Q4 25 | $55.9M | $13.3M | ||
| Q3 25 | $51.8M | $14.9M | ||
| Q2 25 | $51.8M | $14.9M | ||
| Q1 25 | $45.6M | $5.8M | ||
| Q4 24 | $50.3M | $-30.3M | ||
| Q3 24 | $47.0M | $-654.0K | ||
| Q2 24 | $51.1M | $3.3M | ||
| Q1 24 | $49.7M | $2.1M |
毛利率OFGRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率OFGRGEN
| Q4 25 | 25.7% | 9.0% | ||
| Q3 25 | 33.0% | 8.9% | ||
| Q2 25 | 36.1% | 7.6% | ||
| Q1 25 | 33.3% | 3.9% | ||
| Q4 24 | 28.9% | -17.7% | ||
| Q3 24 | 35.4% | -5.1% | ||
| Q2 24 | 39.6% | 1.0% | ||
| Q1 24 | 38.9% | 1.3% |
净利率OFGRGEN
| Q4 25 | 30.3% | 6.7% | ||
| Q3 25 | 27.8% | 7.9% | ||
| Q2 25 | 28.4% | 8.2% | ||
| Q1 25 | 25.5% | 3.4% | ||
| Q4 24 | 27.6% | -17.4% | ||
| Q3 24 | 26.9% | -0.4% | ||
| Q2 24 | 28.4% | 2.2% | ||
| Q1 24 | 28.5% | 1.4% |
每股收益（稀释后）OFGRGEN
| Q4 25 | $1.27 | $0.24 | ||
| Q3 25 | $1.16 | $0.26 | ||
| Q2 25 | $1.15 | $0.26 | ||
| Q1 25 | $1.00 | $0.10 | ||
| Q4 24 | $1.10 | $-0.55 | ||
| Q3 24 | $1.00 | $-0.01 | ||
| Q2 24 | $1.08 | $0.06 | ||
| Q1 24 | $1.05 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.4B | $2.1B |
| 总资产 | $12.5B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资OFGRGEN
| Q4 25 | $1.0B | $767.6M | ||
| Q3 25 | $740.3M | $748.7M | ||
| Q2 25 | $851.8M | $708.9M | ||
| Q1 25 | $710.6M | $697.2M | ||
| Q4 24 | $591.1M | $757.4M | ||
| Q3 24 | $680.6M | $784.0M | ||
| Q2 24 | $740.4M | $809.1M | ||
| Q1 24 | $754.4M | $780.6M |
总债务OFGRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益OFGRGEN
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.3B | $2.0B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
总资产OFGRGEN
| Q4 25 | $12.5B | $2.9B | ||
| Q3 25 | $12.2B | $2.9B | ||
| Q2 25 | $12.2B | $2.9B | ||
| Q1 25 | $11.7B | $2.9B | ||
| Q4 24 | $11.5B | $2.8B | ||
| Q3 24 | $11.5B | $2.8B | ||
| Q2 24 | $11.3B | $2.9B | ||
| Q1 24 | $11.2B | $2.8B |
负债/权益比OFGRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $217.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $199.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 108.1% | 8.9% |
| 资本支出强度资本支出/营收 | 10.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 3.90× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $345.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流OFGRGEN
| Q4 25 | $217.7M | $25.7M | ||
| Q3 25 | $39.5M | $48.1M | ||
| Q2 25 | $35.9M | $28.6M | ||
| Q1 25 | $83.1M | $15.0M | ||
| Q4 24 | $252.5M | $39.2M | ||
| Q3 24 | $58.1M | $49.3M | ||
| Q2 24 | $95.1M | $42.2M | ||
| Q1 24 | $61.0M | $44.7M |
自由现金流OFGRGEN
| Q4 25 | $199.3M | $17.6M | ||
| Q3 25 | $35.5M | $43.4M | ||
| Q2 25 | $31.8M | $21.5M | ||
| Q1 25 | $78.7M | $11.4M | ||
| Q4 24 | $231.2M | $33.6M | ||
| Q3 24 | $51.8M | $42.3M | ||
| Q2 24 | $90.4M | $37.4M | ||
| Q1 24 | $54.8M | $36.4M |
自由现金流率OFGRGEN
| Q4 25 | 108.1% | 8.9% | ||
| Q3 25 | 19.1% | 23.0% | ||
| Q2 25 | 17.4% | 11.8% | ||
| Q1 25 | 44.1% | 6.8% | ||
| Q4 24 | 126.5% | 19.3% | ||
| Q3 24 | 29.6% | 27.3% | ||
| Q2 24 | 50.3% | 24.3% | ||
| Q1 24 | 31.4% | 24.0% |
资本支出强度OFGRGEN
| Q4 25 | 10.0% | 4.1% | ||
| Q3 25 | 2.1% | 2.5% | ||
| Q2 25 | 2.3% | 3.9% | ||
| Q1 25 | 2.4% | 2.1% | ||
| Q4 24 | 11.7% | 3.2% | ||
| Q3 24 | 3.6% | 4.5% | ||
| Q2 24 | 2.6% | 3.1% | ||
| Q1 24 | 3.5% | 5.5% |
现金转化率OFGRGEN
| Q4 25 | 3.90× | 1.93× | ||
| Q3 25 | 0.76× | 3.23× | ||
| Q2 25 | 0.69× | 1.92× | ||
| Q1 25 | 1.82× | 2.57× | ||
| Q4 24 | 5.02× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.86× | 12.70× | ||
| Q1 24 | 1.23× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
